Amphastar Argues To Supreme Court: Hatch-Waxman Patent Safe Harbor Is Too Narrow
WASHINGTON, D.C. — An appellate court’s interpretation of the Hatch-Waxman safe harbor, 35 U.S. Code Section 271(e)(1), is “overly narrow” and puts generic manufacturers at risk of patent suits, Amphastar Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article